Proteins and Peptides
15 September 2017
Tresiba® trial shows that people with type 2 diabetes who avoid severe hypoglycaemia have a reduced risk of deat14 September 2017
Engineered Therapy for Blood Clotting Disorder Shows Early Promise13 September 2017
Bioniz Therapeutics Presents Data Demonstrating the Synergistic Effects of Cytokines IL-15 and IL-21 in Celiac Disease Pathogenesis12 September 2017
Fiasp® significantly improved overall blood sugar control in type 1 diabetes long-term12 September 2017
FDA Accepts Adello Biologic’s Biosimilar Biologics License Application for a Proposed Filgrastim Biosimilar11 September 2017
DiaMedica Announces the Initiation of Phase 2 Trial Evaluating DM199 (Recombinant Human KLK1) in Patients with Acute Ischemic Stroke11 September 2017
amcure Presents Phase I/Ib Study Design for Lead Compound AMC303 at ESMO 2017 Congress11 September 2017
Radius Health Presents Positive Data for TYMLOS™ (abaloparatide) Injection from the ACTIVExtend Trial at ASBMR 2017 Annual Meeting7 September 2017
Bayer submits marketing authorization application for BAY94-9027 for the treatment of Hemophilia A in the EU6 September 2017
Aeglea BioTherapeutics Doses Two Patients in Repeat Dose Part of Phase 1/2 Clinical Trial for the Treatment of Arginase 1 Deficiency6 September 2017
Catalyst Biosciences Announces Positive Factor IX Clinical Data5 September 2017
Medtronic Launches Long Term Clinical Study Program of INFUSE Bone Graft in Two Common Spine Procedures: PLF and TLIF5 September 2017
Cinfa Biotech reports clinical development data for pegfilgrastim biosimilar candidate B12019 at the ESMO Congress 20172 September 2017
Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL30 August 2017
FDA Accepts BioMarin’s Pegvaliase Biologics License Application (BLA) and Grants Priority Review Designation29 August 2017
Victoza® reduces the risk of major cardiovascular events in people with type 2 diabetes with or without prior eventsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports